202 related articles for article (PubMed ID: 8581277)
1. PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.
Brown C; Tanna B; Boarder MR
Br J Pharmacol; 1995 Nov; 116(5):2413-6. PubMed ID: 8581277
[TBL] [Abstract][Full Text] [Related]
2. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
Mateo J; Miras-Portugal MT; Castro E
Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
[TBL] [Abstract][Full Text] [Related]
3. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
Br J Pharmacol; 1996 Jun; 118(3):704-10. PubMed ID: 8762097
[TBL] [Abstract][Full Text] [Related]
4. Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 May; 118(2):428-34. PubMed ID: 8735648
[TBL] [Abstract][Full Text] [Related]
5. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
Ho C; Hicks J; Salter MW
Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
[TBL] [Abstract][Full Text] [Related]
7. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
Piper AS; Hollingsworth M
Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
[TBL] [Abstract][Full Text] [Related]
8. The effect of PPADS as an antagonist of inositol (1,4,5)trisphosphate induced intracellular calcium mobilization.
Vigne P; Pacaud P; Urbach V; Feolde E; Breittmayer JP; Frelin C
Br J Pharmacol; 1996 Sep; 119(2):360-4. PubMed ID: 8886421
[TBL] [Abstract][Full Text] [Related]
9. Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.
Windscheif U; Ralevic V; Bäumert HG; Mutschler E; Lambrecht G; Burnstock G
Br J Pharmacol; 1994 Nov; 113(3):1015-21. PubMed ID: 7858843
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS), a putative P2Y(1) receptor antagonist, blocks signaling at a site distal to the receptor in Madin-Darby canine kidney-D(1) cells.
Shehnaz D; Torres B; Balboa MA; Insel PA
J Pharmacol Exp Ther; 2000 Jan; 292(1):346-50. PubMed ID: 10604969
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of inositol 1,4,5-trisphosphate by co-existing P2Y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells.
Purkiss JR; Wilkinson GF; Boarder MR
Br J Pharmacol; 1994 Mar; 111(3):723-8. PubMed ID: 8019751
[TBL] [Abstract][Full Text] [Related]
12. Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.
Michel AD; Grahames CB; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):562-71. PubMed ID: 8938653
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.
Chen BC; Lee CM; Lin WW
Br J Pharmacol; 1996 Dec; 119(8):1628-34. PubMed ID: 8982511
[TBL] [Abstract][Full Text] [Related]
14. Design and pharmacology of selective P2-purinoceptor antagonists.
Lambrecht G
J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
[TBL] [Abstract][Full Text] [Related]
15. Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries.
Lagaud GJ; Stoclet JC; Andriantsitohaina R
J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):689-703. PubMed ID: 8734982
[TBL] [Abstract][Full Text] [Related]
16. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
Boyer JL; Zohn IE; Jacobson KA; Harden TK
Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
Bültmann R; Dudeck O; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.
Rubino A; Burnstock G
Br J Pharmacol; 1996 Jul; 118(6):1415-20. PubMed ID: 8832066
[TBL] [Abstract][Full Text] [Related]
20. PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.
Ziganshin AU; Hoyle CH; Bo X; Lambrecht G; Mutschler E; Bäumert HG; Burnstock G
Br J Pharmacol; 1993 Dec; 110(4):1491-5. PubMed ID: 8306091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
